| | CYP21A2, LOC106780800 +1 more | Single nucleotide variant | CYP21A2-related disorder | |
| | CYP21A2, LOC106780800 +1 more | Single nucleotide variant | CYP21A2-related disorder | |
| | CYP21A2, LOC106780800 +1 more | Single nucleotide variant | CYP21A2-related disorder | |
| | CYP21A2, LOC106780800 +1 more | Single nucleotide variant | CYP21A2-related disorder | |
| | CYP21A2, LOC106780800 +1 more | Single nucleotide variant (5 prime UTR variant) | not specified +1 more | |
| | CYP21A2, LOC106780800 +1 more (L10del) | Microsatellite (inframe_deletion +1 more) | not specified +1 more | |
| | CYP21A2, LOC106780800 (R26Q) | Single nucleotide variant (missense variant +1 more) | CYP21A2-related disorder | |
| | | Single nucleotide variant (synonymous variant +1 more) | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency +2 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency +1 more | |
| | CYP21A2, LOC106780800 (I78T) | Single nucleotide variant (missense variant +2 more) | CYP21A2-related disorder | |
| | | Single nucleotide variant (intron variant) | not specified +1 more | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | not specified +2 more | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Congenital adrenal hyperplasia +1 more | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | not specified +1 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | not specified | |
| | CYP21A2, LOC106780800 (R103K +1 more) | Single nucleotide variant (missense variant +1 more) | not provided +2 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | not specified | |
| | | Single nucleotide variant (synonymous variant +1 more) | not specified | |
| | | Single nucleotide variant (synonymous variant +1 more) | not specified +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +1 more) | not specified +2 more | GConflicting classifications of pathogenicity |
| | CYP21A2, LOC106780800 (R120S +2 more) | Single nucleotide variant (missense variant) | CYP21A2-related disorder | |
| | | Single nucleotide variant (intron variant) | not specified | |
| | | Single nucleotide variant (intron variant) | not specified | |
| | CYP21A2, LOC106780800 (D184E +2 more) | Single nucleotide variant (missense variant) | not specified +1 more | |
| | | Single nucleotide variant (intron variant) | not specified | |
| | | Single nucleotide variant (synonymous variant) | not specified | |
| | | Single nucleotide variant (intron variant) | not specified | |
| | | Single nucleotide variant (intron variant) | not specified | |
| | | Single nucleotide variant (synonymous variant) | not specified | |
| | CYP21A2, LOC106780800 (V115A +2 more) | Single nucleotide variant (missense variant) | CYP21A2-related disorder | |
| | CYP21A2, LOC106780800 +1 more (S269T +2 more) | Single nucleotide variant (missense variant) | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency +1 more | |
| | | Single nucleotide variant (synonymous variant) | not specified | |
| | CYP21A2, LOC106780800 (V282L +2 more) | Single nucleotide variant (missense variant) | not provided +4 more | GPathogenic/Likely pathogenic |
| | CYP21A2, LOC106780800 (M254V +2 more) | Single nucleotide variant (missense variant) | CYP21A2-related disorder +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (intron variant) | not specified | |
| | | Single nucleotide variant (intron variant) | not specified | |
| | LOC106780800, CYP21A2 +1 more (Q319* +2 more) | Single nucleotide variant (nonsense) | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency +3 more | |
| | CYP21A2, LOC106780800 (P201L +2 more) | Single nucleotide variant (missense variant) | CYP21A2-related disorder | |
| | CYP21A2, LOC106780800 (R312W +2 more) | Single nucleotide variant (missense variant) | not provided +1 more | GConflicting classifications of pathogenicity |
| | CYP21A2, LOC106780800 (R220C +2 more) | Single nucleotide variant (missense variant) | CYP21A2-related disorder +1 more | GPathogenic/Likely pathogenic |
| | CYP21A2, LOC106780800 +1 more (R357W +2 more) | Single nucleotide variant (missense variant) | Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency +2 more | |
| | CYP21A2, LOC106780800 +1 more | Single nucleotide variant (synonymous variant) | not provided +1 more | |
| | CYP21A2, LOC106780800 (P252L +2 more) | Single nucleotide variant (missense variant) | CYP21A2-related disorder | |
| | CYP21A2, LOC106780800 (V263I +2 more) | Single nucleotide variant (missense variant) | CYP21A2-related disorder | |
| | CYP21A2, LOC106780800 (R274L +2 more) | Single nucleotide variant (missense variant) | CYP21A2-related disorder | |
| | CYP21A2, LOC106780800 (R274H +2 more) | Single nucleotide variant (missense variant) | CYP21A2-related disorder +1 more | GConflicting classifications of pathogenicity |
| | CYP21A2, LOC106780800 (R292H +2 more) | Single nucleotide variant (missense variant) | CYP21A2-related disorder +1 more | |
| | CYP21A2, LOC106780800 (P454S +2 more) | Single nucleotide variant (missense variant) | CYP21A2-related disorder +4 more | GPathogenic/Likely pathogenic |
| | CYP21A2, LOC106780800 (F342S +2 more) | Single nucleotide variant (missense variant) | CYP21A2-related disorder | |
| | LOC106780800, CYP21A2 (P483S +2 more) | Single nucleotide variant (missense variant) | not provided +2 more | GConflicting classifications of pathogenicity |
| | CYP21A2, LOC106780800 (R349fs +2 more) | Indel (frameshift variant) | CYP21A2-related disorder +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (synonymous variant) | not specified | |
| | CYP21A2, LOC106780800 (S494N +2 more) | Single nucleotide variant (missense variant) | not specified | |
| | | Single nucleotide variant (3 prime UTR variant) | not specified +1 more | |